Nanologix Financials
| NNLX Stock | USD 0.0001 0.00 0.00% |
Nanologix |
Please note, the imprecision that can be found in Nanologix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nanologix. Check Nanologix's Beneish M Score to see the likelihood of Nanologix's management manipulating its earnings.
Nanologix Stock Summary
Nanologix competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, Hepion Pharmaceuticals, and PTC Therapeutics. NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. Nanologix operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US6300761078 |
| Business Address | 843 North Main |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | nanologix.com |
| Phone | 330 534 0800 |
| Currency | USD - US Dollar |
Nanologix Key Financial Ratios
Nanologix's financial ratios allow both analysts and investors to convert raw data from Nanologix's financial statements into concise, actionable information that can be used to evaluate the performance of Nanologix over time and compare it to other companies across industries.| Return On Equity | -2.14 | |||
| Return On Asset | -1.3 | |||
| Revenue | 892 | |||
| Beta | -33.55 | |||
| Z Score | -3.3 |
Nanologix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanologix's current stock value. Our valuation model uses many indicators to compare Nanologix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanologix competition to find correlations between indicators driving Nanologix's intrinsic value. More Info.Nanologix is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanologix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanologix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanologix Systematic Risk
Nanologix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nanologix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Nanologix correlated with the market. If Beta is less than 0 Nanologix generally moves in the opposite direction as compared to the market. If Nanologix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nanologix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nanologix is generally in the same direction as the market. If Beta > 1 Nanologix moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Nanologix Pink Sheet Analysis
When running Nanologix's price analysis, check to measure Nanologix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanologix is operating at the current time. Most of Nanologix's value examination focuses on studying past and present price action to predict the probability of Nanologix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanologix's price. Additionally, you may evaluate how the addition of Nanologix to your portfolios can decrease your overall portfolio volatility.